Radiotherapy refusal in breast cancer with breast-conserving surgery
- PMID: 37543579
- PMCID: PMC10403910
- DOI: 10.1186/s13014-023-02297-2
Radiotherapy refusal in breast cancer with breast-conserving surgery
Abstract
Background: Although radiotherapy after breast-conserving surgery has been the standard treatment for breast cancer, some people still refuse to undergo radiotherapy. The aim of this study is to identify risk factors for refusal of radiotherapy after breast-conserving surgery.
Methods: To investigate the trend of refusing radiotherapy after breast-conserving surgery in patients with breast cancer using the Surveillance, Epidemiology, and End Results database. The patients were divided into radiotherapy group and radiotherapy refusal group. Survival results were compared using a multivariate Cox risk model adjusted for clinicopathological variables. Multivariate logistic regression was used to analyze the influencing factors of patients refusing radiotherapy after breast-conserving surgery and a nomogram model was established.
Results: The study included 87,100 women who underwent breast-conserving surgery for breast cancer between 2010 and 2015. There were 84,948 patients (97.5%) in the radiotherapy group and 2152 patients (2.5%) in the radiotherapy refusal group. The proportion of patients who refused radiotherapy after breast-conserving surgery increased from 2.1% in 2010 to 3.1% in 2015. The Kaplan-Meier survival curve showed that radiotherapy can improve overall survival (p < 0.001) and breast cancer specific survival (p < 0.001) in the patients with breast-conserving surgery. The results of multivariate logistic regression showed that age, income, marital status, race, grade, stage, subtype and chemotherapy were independent factors associated with the refusal of radiotherapy.
Conclusions: Postoperative radiotherapy can improve the benefits of breast-conserving surgery. Patients with old age, low income, divorce, white race, advanced stage, and no chemotherapy were more likely to refuse radiotherapy.
Keywords: Breast cancer; Breast cancer specific survival; Breast-conserving surgery; Overall survival; Radiotherapy.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients.Tumori. 2010 Nov-Dec;96(6):947-54. Tumori. 2010. PMID: 21388057
-
Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer.BJS Open. 2025 Mar 4;9(2):zraf002. doi: 10.1093/bjsopen/zraf002. BJS Open. 2025. PMID: 40103401 Free PMC article.
-
Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.Radiother Oncol. 2015 Jan;114(1):28-34. doi: 10.1016/j.radonc.2014.08.027. Epub 2014 Sep 15. Radiother Oncol. 2015. PMID: 25236715
-
Adjuvant radiotherapy after breast conserving surgery for breast cancer. Pro.Eur J Cancer. 2000 Jun;36(9):1073-8. doi: 10.1016/s0959-8049(00)00085-x. Eur J Cancer. 2000. PMID: 10854937 Review. No abstract available.
-
Timing of radiotherapy in breast cancer conserving treatment.Cancer Treat Rev. 2002 Feb;28(1):5-10. doi: 10.1053/ctrv.2002.0252. Cancer Treat Rev. 2002. PMID: 12027411 Review.
Cited by
-
Local Control of Advanced Breast Cancer-Debate in Multidisciplinary Tumor Board.J Clin Med. 2025 Jan 15;14(2):510. doi: 10.3390/jcm14020510. J Clin Med. 2025. PMID: 39860516 Free PMC article.
-
Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery.Sci Rep. 2024 Sep 12;14(1):21355. doi: 10.1038/s41598-024-66401-6. Sci Rep. 2024. PMID: 39266585 Free PMC article.
-
Synergistic Antitumor Effects of Caerin Peptides and Dendritic Cell Vaccines in a 4T-1 Murine Breast Cancer Model.Vaccines (Basel). 2025 May 28;13(6):577. doi: 10.3390/vaccines13060577. Vaccines (Basel). 2025. PMID: 40573908 Free PMC article.
-
Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk.Cancers (Basel). 2024 Jan 5;16(2):239. doi: 10.3390/cancers16020239. Cancers (Basel). 2024. PMID: 38254731 Free PMC article.
-
Perceptions, educational expectations and knowledge gaps of patients with non-metastatic breast cancer regarding radiotherapy: Integrative review.Tech Innov Patient Support Radiat Oncol. 2025 Apr 20;34:100312. doi: 10.1016/j.tipsro.2025.100312. eCollection 2025 Jun. Tech Innov Patient Support Radiat Oncol. 2025. PMID: 40321895 Free PMC article. Review.
References
-
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–1241. doi: 10.1056/NEJMoa022152. - DOI - PubMed
-
- Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716. doi: 10.1016/S0140-6736(11)61629-2. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical